No Data
No Data
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics...
Kodiak Sciences (KOD) Receives a Sell From Barclays
Express News | Kodiak Sciences Inc : Jefferies Cuts Target Price to $4 From $7
Kodiak Sciences | 10-Q: Quarterly report
Express News | Kodiak Sciences Inc - Believe That Our Current Cash Will Support Our Current and Planned Operations Into 2026
Express News | Kodiak Sciences Inc - Ended Q1 of 2024 With $245.9 Mln of Cash and Cash Equivalents